Updates
ANDA APPROVAL FROM USFDA FOR ARIPIPRAZOLE ORALLY DISINTEGRATING TABLETS13-12-2017
Updates
QUARTERLY FINANCIAL RESULTS FOR PERIOD ENDED 30TH JUNE 2017 AND 30TH SEPTEMBER 201727-11-2017
Updates
PUBLICATION FOR SUBMISSION OF EXPRESSION OF INTEREST UNDER INSOLVENCY AND BANKRUPTCY CODE,201616-11-2017
Updates
APPOINTMENT OF RESOLUTION PROFESSIONAL (RP) UNDER INSOLVENCY AND BANKRUPTCY CODE,201616-11-2017
Certificate Under Regulation 40(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015
Certificate under Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,201526-10-2017
Certificate Under Regulation 7(3) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations,2015
Certificate under Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations,201525-10-2017
Shareholding for the Period Ended September 30, 2017
Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click here21-10-2017
Statement Of Investor Complaints For The Quarter Ended September 30,2017
Statement of investor complaints for the quarter ended September 30,201720-10-2017
Updates
WAIVER OF PENALTY -NON SUBMISSION OF FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30,201706-10-2017
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Adurjee & Bros. Pvt Ltd28-09-2017